Join MetX

Become a Partner in Research

Metrodora is excited to partner with patients living with chronic, complex conditions through our landmark study.

We invite you, your family members, caregivers, friends, and others to partner with us and join this important study.

People who join the study will share their health information and biospecimens to be used for research. MetX will aid in creating a better understanding for what causes these chronic conditions and help develop better testing and treatment options.

Part 1

Metrodora Connect

Metrodora Connect is a digital health toolkit that will pull together data from every part of a participant’s journey—from fully integrated medical records, to longitudinal symptoms and intervention tracking, to biometrics data from personal wearables, questionnaires, and biomechanical data. This engaging tool turns patients into true partners in our research and allows them to take an active role in sharing data, tracking their symptoms, participating in surveys and more.

Part 2

Metrodora Biorepository

Metrodora is home to the most comprehensive collection of biological specimens from participants – including blood, urine, saliva, tissues and more. Collected longitudinally, researchers will use these biospecimens and data to unlock advances in genetic, antibody and cellular therapies. We’re partnering with the most advanced and emerging technologies in genetics, epigenetics, gene expression, proteins, metabolites, and cellular analyses—and using the latest advances in AI to analyze datasets at a scale that’s never been possible before.

Who is eligible to join the study?

Everyone is eligible to participate, regardless of age, diagnosis, or gender, so long as they are living within the United States. We welcome all individuals to contribute to this important research and help make a significant impact in our understanding of chronic multi-system disorders. Participation is entirely voluntary and can be withdrawn at any time.

How is the data used?

The data collected will be made accessible to the Metrodora research team, as well as outside research partners, to help us understand complex multi-system disorders. It is stored in a secure, HIPAA compliant system, and Meaningful Use Certified EDC HIEBusTM platform. The biological specimens are stored on-site, at Metrodora Institute, in a secure room with limited access.

How does this study improve care?

Our focus is to use methods such as genetic sequencing and immune profiling to return results to patients. We aim to reclassify diseases based on what’s happening biologically and create different clusters of patients that may respond positively to more specific treatments. This study is a large-scale effort to help the industry find the right groups of patients that are most likely to see positive impact from a drug based on their biology—thereby increasing the chances of success for clinical trials.

Joining is free, voluntary, and participants can opt out anytime.

If you have any questions, please reach out to [email protected]

Share your data to improve patient outcomes!

Link electronic health records

Track your symptoms

Connect wearable devices

Download reports to share with providers

Connect to clinical trials

Patients want access to the best care available today, but they also want to help discover the cures of tomorrow.

At Metrodora, we partner with patients as well as the rest of the industry on transformative research to help accelerate the path to cures — and with the launch of MetX, we are one step closer on that journey